Warfarin versus aspirin for stroke prevention (BAFTA) - Authors' reply

Lancet

Volumn 370, Issue 9599, 2007, Pages 1606-1607

  Mant, Jonathan ^a   Hobbs, FD Richard ^a   Fletcher, Kate ^a   Roalfe, Andrea ^a   Fitzmaurice, David ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

BLEEDING; DRUG SAFETY; GERIATRIC CARE; GERIATRIC PATIENT; HUMAN; LETTER; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; STROKE; TREATMENT OUTCOME;

EID: 85066726745     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61680-8     Document Type: Letter

References (2)

1. Garcia D., and Hylek E. Stroke prevention in elderly patients with atrial fibrillation. Lancet 370 (2007) 460-461
2. Mant J., Richards S., Hobbs F., et al. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population. BMC Cardiovasc Disord 3 (2003) 9